drugset / Trial / NCT06117917

Esketamine Combined With Pregabalin on CPSP in Spinal Patients.

NCT06117917

Phase 2/3 Unknown 150 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Chronic postsurgical pain has become one of the most common complications of surgery. The quality of life will be impacted once the postsurgical patients are combined with persistent pain. What's more, the postsurgical pain may increase other adverse outcomes. It's important to find a better way to keep the postsurgical patients away from postoperative pain. Esketamine and pregabalin have become potentially effective drugs on CPSP.

Timeline

Start
2023-11-10
Primary completion
2024-05-31
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.12 mg/kg Intravenous
Subject Pregabalin Small molecule 75 mg

Indications